J&J's prostate cancer drug Zytiga approved in EU

By Admin
Men with advanced cases of prostate cancer who have already undergone chemotherapy have been allowed access to a new, secondary treatment drug for the...

Men with advanced cases of prostate cancer who have already undergone chemotherapy have been allowed access to a new, secondary treatment drug for the disease.

Zytiga, manufactured by pharmaceutical company Johnson & Johnson, has just been approved for use in Europe and in April it was given the go-ahead in America by the US Food and Drug Administration (FDA).

The new drug was approved by the European Commission after an accelerated review by the European Medicines Agency.

In both the US and Europe, Zytiga has been approved for use when taken in conjunction with the prednisone steroid.

To read the latest edition of Healthcare Global, click here

The drug works by preventing the production of the testosterone hormone in the testes and the tumour itself, therefore limiting, if not stooping, the tumour from growing.  

In a statement released by Johnson & Johnson, the company commented: “A trial of nearly 1,200 patients showed that those treated with Zytiga and prednisone lived an average of four months longer than those treated with prednisone and a options.”

It is thought the drug is likely to be well received by patients as other treatments of a similar nature are only available in injection form, whereas Zytiga is a once-a-day oral pill.

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Dongxu Sun, CEO at TrueBinding, shares how its research & antibody drug development is fighting illnesses such as Alzheimer’s Disease, stroke & more

Cardinal Health’s clinically integrated pharma supply chain

Peter Siavelis, SVP & General Manager, Health System and Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

This week in Healthcare Digital, we looked at digital skills for healthcare leaders, medical technology & acoustic AI used in digital cough monitoring

Hospitals must embrace IoMT device security

Hospitals

Mental health support for working women and mothers

Digital Healthcare

Digital evolution delivers better healthcare outcomes

Digital Healthcare